Novo Nordisk Adds Mars Chief as Board Observer Amid U.S. Consumer Push
Novo Nordisk has named Poul Weihrauch, CEO of Mars, as an observer to its board and at the same meeting elected three new board members. The moves come as the company steps up consumer-oriented initiatives in the competitive U.S. obesity market, including a cash-pay roll-out of its Wegovy pill and expanded telehealth and retail approaches.